Time will tell: 5 years of TRANSCEND
0 citationsBlood
Michael Dickinson
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
474Publications signalées
11701Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
CAR-T cell therapy researchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchBiosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research
Publications récentes
Dynamic risk stratification using early CAR ‐T expansion in R/R LBCL treated with axicabtagene ciloleucel
Brydon Panozzo, Samuel Robinson, Adrian Minson, Jian Li et autres
0 citationsBritish Journal of Haematology
CAR transgenic T-cell lymphoproliferative neoplasm (CTTLN): malignant transformation of cellular immunotherapy
Francis Baumgartner, Michael Dickinson, Piers Blombery
0 citationsBlood
Rewiring immunity with in vivo CAR T cell engineering
Clare Y. Slaney, Rachel Xu, Shiyi Wu, Kevin Sek et autres
0 citationsNature Cancer
Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial
Michael Dickinson, Leanne Berkahn, Judith Trotman, Jason Butler et autres
0 citationsBritish Journal of Haematology
Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma: Phase 1b dose‐escalation study
William Townsend, Nilanjan Ghosh, Martin Hutchings, Michael Dickinson et autres
0 citationsBritish Journal of Haematology
Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL
Brydon Panozzo, Matthew Rubic, Jian Li, Catelyn Cashion et autres
0 citationsBlood Advances
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
Martin Hutchings, Michael Dickinson, Giuseppe Gritti, Carmelo Carlo‐Stella et autres
0 citationsNature Medicine
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis
Matthew R. Wilson, Katharine L. Lewis, Amy A. Kirkwood, Kate Cwynarski et autres
1 citationJournal of Clinical Oncology
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
Martin Dreyling, Martin Dreyling, Jeanette Doorduijn, Eva Soca Giné et autres
9 citationsThe Lancet
Glofitamab monotherapy in patients with Richter transformation: safety and efficacy from a phase 1 study
Carmelo Carlo‐Stella, Martin Hutchings, Fritz Offner, Estefania Mulvihill et autres
0 citationsBlood Advances
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses
Jamie E. Flerlage, Dennis A. Eichenauer, Michael Fuchs, Sylvia Hartmann et autres
1 citationBlood Advances
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.